Urinary excretion of glycosaminoglycans in patients with postmenopausal osteoporosis.
The organic bone matrix contains glycosaminoglycans (GAG) of which the precise function and importance in bone mineralisation are still unclear. We examined 85 persons--35 healthy women (25 premenopausal [preMP] mean aged 40.7 years; 10 menopausal [MP] mean aged 59.3 years) and 50 patients with postmenopausal osteoporosis [PMOP] at a mean age 60.4 years. The dynamic of urinary excretion of GAG was measured in 24-hour collected urine by precipitation with cetylpyridinum chloride and spectrophotometry at 560 nm, corrected for the level of excretion of creatinine. There was a significant increase in GAG excretion in patients with PMOP compared with healthy persons (8.25 mg/g and 9.53 mg/g vs 24.11 mg/g; p < 0.0001). A significant positive correlation was established between GAG and calcium urinary excretion and a negative one between GAG and serum estradiol levels. During the treatment with calcitonin the excretion of GAG was decreased which can be used for monitoring the changes of bone metabolism.
Todorova
S
S
Research Institute of Endocrinology and Geriatrics, Sofia, Bulgaria.
Antov
G
G
Levi
S
S
Michailova
A
A
Topalova
N
N
Toneva
Z
Z
D000328:Adult; D002116:Calcitonin / Q000627:therapeutic use; D002118:Calcium / Q000652:urine; D003404:Creatinine / Q000652:urine; D004958:Estradiol / Q000097:blood; D005260:Female; D006025:Glycosaminoglycans / Q000652:urine*; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000097:blood / Q000652:urine*
D006025:Glycosaminoglycans; D004958:Estradiol; D002116:Calcitonin; D003404:Creatinine; D002118:Calcium